中国循证儿科杂志 ›› 2018, Vol. 13 ›› Issue (5): 327-331.

• 论著 • 上一篇    下一篇

儿童白塞病27例病例系列报告

李建国1,王媛1,周志轩2,苏改秀3,李胜男1,康闵1,赖建铭1,朱佳4,侯俊1,许瑛杰1   

  1. 1. 首都儿科研究所附属儿童医院
    2. 首都儿科研究所附属儿童医院儿童风湿免疫科
    3. 首都儿科研究所附属儿童医院风湿免疫科
    4.
  • 收稿日期:2018-08-01 修回日期:2018-12-01 出版日期:2018-10-25 发布日期:2018-10-25
  • 通讯作者: 周志轩

Retrospective analysis of 27 Chinese children with Behcet's disease

  • Received:2018-08-01 Revised:2018-12-01 Online:2018-10-25 Published:2018-10-25

摘要: 目的:分析儿童白塞病(BD)的临床特征、诊治及预后,以提高对该病的诊治水平。 方法:纳入2006年8月1日至2016年8月1日在首都儿科研究所附属儿童医院住院的完全符合BD诊断标准(1990年国际BD研究小组制定的诊断标准或2014年BD国际评分标准)的患儿。从电子病历系统中截取患儿的一般资料、起病年龄、确诊年龄、临床表现、辅助检查结果、治疗情况和随访资料。 结果:27例患儿进入本文分析,男13例,起病年龄8个月至14岁,平均(6.8±4.0)岁,发病至临床确诊时间中位数为6个月。27例均有口腔溃疡,18例合并肛周溃疡和(或)外生殖器溃疡,15例(55.6%)有胃肠道症状(包括腹痛、腹泻和血便),3例(11.1%)有结膜炎和(或)角膜炎,14例(51.9%)有皮疹(以红色斑丘疹最常见)。其中3例考虑原发免疫缺陷病(PID)。行胃肠镜检查的20例均显示胃肠道受累,其中7例无消化道症状。25例接受糖皮质激素治疗,其中8例单用甲基泼尼松龙,10例联合环磷酰胺或甲氨蝶呤,3例联合CTX及沙利度胺,1例联合沙利度胺,3例联合生物制剂;2例应用白芍总苷胶囊。27例中失访4例,23例平均随访(36.2±39.1)个月,13例病情稳定,7例反复复发,3例死亡。 结论:儿童BD起病隐匿,首发症状无特异性,多以口腔溃疡起病;与成人BD相比,眼部和皮肤受累较少,消化道受累较为常见;经过治疗后多数病情可以缓解,预后较好。对于严重BD患儿,尤其对治疗无反应者需考虑PID。

关键词: Behcet’s disease, Children, 白塞病, 儿童

Abstract: Objective:To improve the diagnosis and treatment of Behcet's disease(BD), the clinical features of BD cases have been analyzed. Methods:Children with BD diagnosed in Children's Hospital, Capital Institute of Pediatrics from Aug 1, 2006 to Aug 1, 2016 were included. All patients were diagnosed according to 1990 International Behcet's Disease Diagnostic Criteria or 2014 International Criteria for Behcet's Disease. Results:Totally 27 cases were included, with 13 males and 14 females, aged from 8 months to 14 years(6.8±4.0 years). The median time from onset to diagnosis was 6 months. All of 27 children had oral ulcer. Gastrointestinal symptoms were found in 15 cases (55.6%), conjunctivitis and keratitis in 3 cases(11.1%),rash in 14 cases (51.9%). Twenty cases undergoing endoscope examination all had positive endoscopic findings, 7 of whom did not have any gastrointestinal symptoms. Twenty-five cases received corticosteroids therapy. Among them, 8 cases only received methylprednisolone (MP), 10 cases received MP and CTX/MTX, 3 cases received MP, CTX and thalidomide, 1 case received MP and thalidomide, and 3 cases received MP and biologics. The other 2 cases were treated with total glucosides of paeony capsules. Four cases were lost to follow-up, and the other 23 cases were followed up for 36.2±39.1 months (0.5 months to 9 years), of whom 13 cases were stable, 7 cases relapsed and 3 cases died. Conclusion:The onset symptoms of BD in children were very obscure, and many children start with oral ulcers. Compared with BD adults, BD children were suffered less from eyes and skin symptoms, while digestive tract involvement was more common. After treatment, most of the BD children could be relieved and the prognosis is generally good. As to refractory cases, especially those who did not respond to treatment, primary immunodeficiency should be suspected.